World Wires · story 26047 · unverified · 1 source(s)

Nurix Therapeutics Announces First Patient Enrolled in Phase 1b/2 Combination Study of Bexobrutideg in Chronic Lymphocytic Leukemia

First patient enrolled in cohort combining bexobrutideg with venetoclax

Open in the desk

Coverage

• Nurix Therapeutics Announces First Patient Enrolled in Phase 1b/2 Combination Study of Bexobrutideg in Chronic Lymphocytic Leukemia GlobeNewswire: public companies · tier D · clear net · 2026-10-07 05:00 UTC

What this site indexes